Hadeel Swed: My First First-Author Publication in Thrombosis Research
Hadeel Swed, PhD Student at IBMB, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Thrombosis Research, adding:
“I’m very happy to share that my first paper as a first-author during my PhD has now been published in Thrombosis Research!
In this work, we developed a human-cell recombinant thrombin platform with enhanced activity toward fibrinogen, with the aim of making it a useful tool for in-vitro studies.
A lot of work, learning, troubleshooting, and patience went into this one, so seeing it finally published feels really special.
Very grateful to everyone who was part of this journey.”
Title: A human-cell recombinant prethrombin-2 platform producing thrombin with enhanced fibrinogen processing for in vitro applications
Authors: Hadeel Swaid, Soraia R. Mendes, Pablo Fuentes-Prior, Arturo Rodríguez-Banqueri, F. Xavier Gomis-Rüth
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 00:26Barbara Adams Krolak: Discussing the Growing Need for Blood Clot Prevention in Asia
-
Oct 9, 2026, 23:59Ana Pedrero Gil: Is Coagulopathy with Fibrinolysis Present in All Obstetric Hemorrhages?
-
Oct 9, 2026, 23:57Exploring the Psychosocial Needs of People with Bleeding Disorders in Kyrgyzstan – EAHAD
-
Oct 9, 2026, 23:53Bernard Slater Jr.: Serving on the Advisory Council for the NBDF West Virginia Chapter
-
Oct 9, 2026, 23:53Aurelio Maggio: Thalassemia Reports Real-Time Impact Factor Rises to 1.760
-
Oct 9, 2026, 23:52Stronger Connections, Stronger Organizations – World Federation of Hemophilia
-
Oct 9, 2026, 23:46Samuel Misiani Mbunya: Advancing Sickle Cell Care Through Collaboration at the 21st ASCAT Conference
-
Oct 9, 2026, 23:38Micheal Avoseh: Exploring Nanoparticle-Based Therapies for Thrombosis and Vascular Inflammation
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation